References
- GalaskoDExpanding the repertoire of biomarkers for Alzheimer’s disease: targeted and non-targeted approachesFront Neurol2015625626733934
- WUSTLWashington University of St. Luis Available from: http://neuroscienceresearch.wustl.edu/News.aspxAccessed May 11, 2017
- Alzheimer’s AssociationA future without Alzheimer’s;2017 Available from: http://www.alz.org/research/overview.aspAccessed May, 2017
- ZetterbergHApplying fluid biomarkers to Alzheimer’s diseaseAm J Physiol Cell Physiol20173131C3C1028424166
- World Health OrganizationInternational Alzheimer’s DiseaseDementia: a public health priority. WHO2012 Available from: http://www.who.int/mental_health/publications/dementia_report_2012
- HurdMDMartorellPDelavandeAMullenKJLangaKMMonetary costs of dementia in the United StatesN Engl J Med2013368141326133423550670
- FiandacaMSZhongXCheemaAKPlasma 24-metabolite panel predicts preclinical transition to clinical stages of Alzheimer’s diseaseFront Neurol2015623726617567
- O’BryantSEMielkeMMRissmanRABlood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinicAlzheimers Dement2017131455827870940
- PanegyresPKChenHYDifferences between early and late onset Alzheimer’s diseaseAm J Neurodegener Dis20132430030624319647
- ChintamaneniMBhaskarMBiomarkers in Alzheimer’s disease: a reviewISRN Pharmacol20122012984786622811931
- DuboisBFeldmanHHJacovaCResearch criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteriaLancet Neurol20076873474617616482
- CarswellCJWinZMuckleKClinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patientsJ Neurol Neurosurg Psychiatry201889329429929018162
- RabinoviciGDRosenHJAlkalayAAmyloid vs FDG-PET in the differential diagnosis of AD and FTLDNeurology201177232034204222131541
- SuYBlazeyTMOwenCJCorrection: quantitative amyloid imaging in autosomal dominant Alzheimer’s disease: results from the DIAN study groupPLoS One2016119e016366927649320
- MorrisJKHoneaRAVidoniEDSwerdlowRHBurnsJMIs Alzheimer’s disease a systemic disease?Biochim Biophys Acta2014184291340134924747741
- WurtmanRBiomarkers in the diagnosis and management of Alzheimer’s diseaseMetabolism2015643 Suppl 1S47S5025468144
- SelkoeDJHardyJThe amyloid hypothesis of Alzheimer’s disease at 25 yearsEMBO Mol Med20168659560827025652
- TakahashiRHNagaoTGourasGKPlaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer’s diseasePathol Int201767418519328261941
- PláteníkJFišarZBuchalRGSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer’s disease and depressionProg Neuropsychopharmacol Biol Psychiatry201450839324334212
- Martins-de-SouzaDBiomarkers for psychiatric disorders: where are we standing?Dis Markers20133511224167343
- MaesOCSchipperHMChertkowHMWangEMethodology for discovery of Alzheimer’s disease blood-based biomarkersJ Gerontol A Biol Sci Med Sci200964663664519366883
- BlennowKA review of fluid biomarkers for Alzheimer’s disease: moving from CSF to bloodNeurol Ther20176Suppl 1152428733960
- LewczukPRiedererPO’BryantSECerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the consensus of the task force on biological markers in psychiatry of the world federation of societies of biological psychiatryWorld J Biol Psychiatry201819424432829076399
- KhanTKAlkonDLPeripheral biomarkers of Alzheimer’s diseaseJ Alzheimers Dis201544372974425374110
- HumpelCIdentifying and validating biomarkers for Alzheimer’s diseaseTrends Biotechnol2011291263220971518
- KvartsbergHDuitsFHIngelssonMCerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer’s diseaseAlzheimers Dement201511101180119025533203
- FolchJPetrovDEttchetoMCurrent research therapeutic strategies for Alzheimer’s disease treatmentNeural Plast20162016115
- HenekaMTCarsonMJEl KhouryJNeuroinflammation in Alzheimer’s diseaseLancet Neurol201514438840525792098
- VoyleNBakerDBurnhamSCBlood protein markers of neocortical amyloid-β burden: a candidate study using SOMAscan technologyJ Alzheimers Dis201546494796125881911
- HuynhRAMohanCAlzheimer’s disease: biomarkers in the genome, blood, and cerebrospinal fluidFront Neurol2017810228373857
- NicolasGWallonDCharbonnierCScreening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessonsEur J Hum Genet201624571071626242991
- FooJNLiuJJTanEKWhole-genome and whole-exome sequencing in neurological diseasesNat Rev Neurol20128950851722847385
- MattssonNZetterbergHJanelidzeSPlasma tau in Alzheimer diseaseNeurology201687171827183527694257
- MattssonNAndreassonUZetterbergHBlennowKAlzheimer’s disease neuroimaging I. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer diseaseJAMA Neurol20177455756628346578